Stock Notes

IOL Chemicals and Pharmaceuticals

Every Finvezto stock note on IOL Chemicals and Pharmaceuticals, dated and newest first. Coverage spans specialty chemicals.

1 note and counting
09 Sep 2026
IOL Chemicals will spend Rs 350 crore on a new 6,000 tonne ibuprofen unit at Barnala, lifting capacity by half to 18,000 tonnes.
The unit is fully backward integrated and funded from internal accruals. The company also announced a new formulations CDMO line and a dedicated specialty chemicals facility at the same site.
Finvezto Membership

Get the research behind the notes

Stock notes are the free daily layer. The membership carries the full Flexi-Wealth system: an ETF core portfolio with monthly rebalancing signals, fifteen quality-momentum stocks with exact weightages every month, options income and hedging recommendations, and the institutional data toolkit. One flat membership covers everything.

Become a Member Read free sample research →

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.